Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.5 GBX | 0.00% | -1.43% | +4.55% |
Mar. 19 | Darktrace strategy chief sells GBP4 million shares | AN |
Mar. 15 | Trident Royalties welcomes US government loan for lithium project | AN |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- Low profitability weakens the company.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- With an expected P/E ratio at 33.69 and 134.24 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.55% | 126M | - | ||
-7.62% | 111B | A- | ||
-1.53% | 90.88B | C+ | ||
+15.14% | 60.96B | C | ||
+0.88% | 58.51B | - | B+ | |
+9.79% | 41.34B | A- | ||
+8.15% | 41.32B | C+ | ||
+17.10% | 34.21B | A- | ||
+0.97% | 24.31B | B | ||
-5.28% | 22.02B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TRR Stock
- Ratings Trident Royalties Plc